A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization
Authors
Keywords
-
Journal
ANGIOGENESIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-16
DOI
10.1007/s10456-020-09745-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains In Vivo
- (2019) Hui Peng et al. Molecular Therapy-Methods & Clinical Development
- Assessment of in vitro cytotoxic and genotoxic activities of some trimethoprim conjugates
- (2018) Devrim Güzel Bayülken et al. CYTOTECHNOLOGY
- A drug-tunable gene therapy for broad-spectrum protection against retinal degeneration
- (2018) Clayton P. Santiago et al. MOLECULAR THERAPY
- Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
- (2018) Hemal Mehta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Retinal Vasculature in Development and Diseases
- (2018) Ye Sun et al. Annual Review of Vision Science
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- Involvement of a gut–retina axis in protection against dietary glycemia-induced age-related macular degeneration
- (2017) Sheldon Rowan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
- (2016) Robert L. Avery et al. JAMA Ophthalmology
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- AAV2 Delivery of Flt23k Intraceptors Inhibits Murine Choroidal Neovascularization
- (2015) Xiaohui Zhang et al. MOLECULAR THERAPY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
- (2013) Ling Luo et al. ACS Nano
- Ligand-switchable Substrates for a Ubiquitin-Proteasome System
- (2011) Emily L. Egeler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System
- (2010) Mari Iwamoto et al. CHEMISTRY & BIOLOGY
- Self-complementary AAV Vectors; Advances and Applications
- (2008) Douglas M McCarty MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search